Therefore, more in-depth and complex research is needed to thoroughly clarify the mechanism of PCSK9 in Hcy-induced atherosclerosis, to provide more professional evidence for clinical intervention in patients with HHcy-related ASCVD. This evidence concerns the gene PCSK9 and atherosclerosis.